Medicine & Health

A new study from Washington University School of Medicine shows that treatment with an immune-boosting protein called interleukin 7 (IL-7) in combination with radiation improves survival in mice with glioblastoma.

Researchers at the McKelvey School of Engineering and the School of Medicine at Washington University are launching the Women’s Health Technologies Initiative, which will focus on innovative therapies supporting female reproductive health.

An international study involving researchers at Washington University School of Medicine analyzed the risk factors for serious health outcomes in kids who had COVID-19. Researchers found that children up to age 18 who had tested positive for COVID-19 were at low risk for severe health problems.

Two new studies from Washington University School of Medicine have identified a previously unrecognized pathway of cell death — named lysoptosis — and demonstrate how it could lead to new therapies for cervical cancer.

Researchers at Washington University School of Medicine have received three grants totaling more than $6.8 million to advance research on a novel imaging system to monitor uterine contractions. The electromyometrial imaging system, called EMMI, was invented and developed at Washington University.

A new study by researchers at Washington University School of Medicine and St. Jude Children’s Research Hospital helps explain why mRNA vaccines have been so successful at preventing severe disease.

Researchers at Washington University School of Medicine are working to develop new treatments for two types of devastating parasitic infections common in sub-Saharan Africa and Central and South America: river blindness and intestinal worm infections.

Longtime St. Louis benefactor Joanne Knight has committed up to $11.5 million to Washington University School of Medicine in St. Louis to support an innovative clinical trial aimed at preventing Alzheimer’s disease by treating people before the first signs of the illness appear in the brain.

Researchers at Washington University School of Medicine are conducting an Alzheimer’s prevention trial with young adults from high-risk families to evaluate whether an investigational drug can clear a key Alzheimer’s protein, amyloid beta, and slow or stop the disease.